<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33754899</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>7-8</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>SOD1-related ALS with anticipation in a large family from Martinique.</ArticleTitle><Pagination><StartPage>545</StartPage><EndPage>551</EndPage><MedlinePgn>545-551</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2021.1900870</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a rare neurological disorder that causes degeneration of upper and lower motor neurons and their axons. ALS is mostly sporadic, but there are familial forms. In more than half of the familial forms, a pathogenic variant is found in one of the following genes: <i>C9ORF72</i>, <i>SOD1</i>, <i>TDP-43</i>, <i>FUS</i>, and <i>VCP</i>. <i>SOD1</i> is the 2nd most common gene involved in genetic forms of ALS. Genotype-phenotype relationships are occasionally established in genetic forms of ALS associated with <i>SOD1</i> mutations pathogenic variants. The c.281G&#x2009;&gt;&#x2009;T (p.[G93V]) variant in <i>SOD1</i> is associated with a rarely described and unexplained anticipation phenomenon. We report a large family from Martinique in whom ALS is associated with a c.281G&#x2009;&gt;&#x2009;T (p.[G93V]) pathogenic variant in <i>SOD1</i> and a statistically suggested anticipation. A whole-exome study and detection of CNVs (CoDESeq) from 3 affected members of this family revealed the presence of variants of uncertain signification (VUS) in other ALS genes. VUS in <i>DCTN1</i> and <i>NEFH</i> were present in patients of the 2nd generation, and CNVs involving <i>UBQLN2</i> and <i>C21orf2</i> were found in the youngest case of the family.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giguet-Valard</LastName><ForeName>Anna-Gaelle</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Neurological and Neuromuscular Rare disorders department, CERCA, University Hospital Center of Martinique, Martinique, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellance</LastName><ForeName>R&#xe9;mi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurological and Neuromuscular Rare disorders department, CERCA, University Hospital Center of Martinique, Martinique, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeannin</LastName><ForeName>S&#xe9;verine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurological and Neuromuscular Rare disorders department, CERCA, University Hospital Center of Martinique, Martinique, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duclos</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurological and Neuromuscular Rare disorders department, CERCA, University Hospital Center of Martinique, Martinique, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olive</LastName><ForeName>Pascale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Neurological and Neuromuscular Rare disorders department, CERCA, University Hospital Center of Martinique, Martinique, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allard-Saint-Albin</LastName><ForeName>Oriane</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Neurological and Neuromuscular Rare disorders department, CERCA, University Hospital Center of Martinique, Martinique, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cazeneuve</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Center of Paris, La Piti&#xe9; Salp&#xe9;tri&#xe8;re Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clot</LastName><ForeName>Fabienne</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University Hospital Center of Paris, La Piti&#xe9; Salp&#xe9;tri&#xe8;re Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sophie</LastName><ForeName>Pittion-Vouyovitch</ForeName><Initials>PV</Initials><AffiliationInfo><Affiliation>Genetic Department, University Hospital of Nancy, Hospital of Brabois, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnetche</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Rheumatology Department/FHU ACRONIM/Rare Systemic Autoimmune Diseases Reference Center, Bordeaux University, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith-Ravin</LastName><ForeName>Juliette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research group BIOSPHERES/AREBIO, University of Antilles-Campus Schoelcher, Martinique, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goizet</LastName><ForeName>Cyril</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, National Reference Center for Rare Diseases 'Neurogenetic', Pellegrin Hospital, Bordeaux University Hospital, Bordeaux, France and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rare Diseases Laboratory: Genetics and Metabolism (MRGM), INSERM U1211, Bordeaux University, Bordeaux, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008395" MajorTopicYN="N" Type="Geographic">Martinique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CoDE-Seq method</Keyword><Keyword MajorTopicYN="N">Genetic Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Next Generation Sequencing</Keyword><Keyword MajorTopicYN="N">anticipation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>12</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33754899</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1900870</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>